机构:[a]Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[b]Department of Biotherapy, Cancer Center and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China四川大学华西医院[c]Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[d]Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[e]Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[f]Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[g]Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[h]Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Jianjun Gao is supported by
NCI/NIH grant R01 CA254988-01A1, a Doris Duke Clinical Scientist Development
Award (#2018097), an MD Anderson Physician Scientist Award, a
Khalifa Physician Scientist Award, an Andrew Sabin Family Foundation
Fellows Award, MD Anderson Faculty Scholar Award, the David H. Koch
Center for Applied Research of Genitourinary Cancers, the Wendy and
Leslie Irvin Barnhart Fund, and the Joan and Herb Kelleher Charitable
Foundation. This study was also supported by SMF Core Grant
CA016672 (SMF) and the IRG start-up research funds provided to L.W.
by MD Anderson Cancer Center. P.M. is supported by a career development
award from the American Society of Clinical Oncology, by an MD
Anderson Khalifa Scholar Award, and by an MD Anderson Physician-
Scientist Award. Omar Alhalabi is supported by a young investigator
award from the Conquer Cancer Foundation of the American Society of
Clinical Oncology.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|2 区肿瘤学2 区泌尿学与肾脏学
最新[2023]版:
大类|1 区医学
小类|1 区肿瘤学1 区泌尿学与肾脏学
第一作者:
第一作者机构:[a]Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[*1]Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
共同第一作者:
通讯作者:
通讯机构:[a]Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA[*1]Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
推荐引用方式(GB/T 7714):
Omar Alhalabi,Yueting Zhu,Ameer Hamza,et al.Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.[J].European urology oncology.2021,doi:10.1016/j.euo.2021.10.006.
APA:
Omar Alhalabi,Yueting Zhu,Ameer Hamza,Wei Qiao,Yiyun Lin...&Jianjun Gao.(2021).Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer..European urology oncology,,
MLA:
Omar Alhalabi,et al."Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.".European urology oncology .(2021)